CCTN - 长效可逆避孕药的临床评估-猫眼课题宝

CCTN - 长效可逆避孕药的临床评估

批准号：

9924402

负责人：

MITCHELL CREININ

金额：

$39.55万

依托单位：

UNIVERSITY OF CALIFORNIA AT DAVIS

依托单位国家：

美国

项目类别：

财政年份：

2015

资助国家：

美国

项目状态：

已结题

起止时间：

2015-09-25 至 2022-09-27

来源：

https://reporter.nih.gov/project-details/9924402

关键词：

Age Attitude Chlamydia Clinical Trials Network Contraceptive Agents Contraceptive History Contraceptive methods Devices Effectiveness Eligibility Determination Enrollment Frequencies Future Gonorrhea Guidelines Gynecology Hemorrhage Implant Incidence Informed Consent Instruction Lead Medical Muscle Cramp National Institute of Child Health and Human Development Pain Pap smear Pattern Pharmaceutical Preparations Pregnancy Pregnancy Tests Procedures Protocols documentation Randomized Randomized Controlled Clinical Trials Recording of previous events Reproductive History Safety Sampling Specific qualifier value Ultrasonography Urine Vaginal Ring Visit Woman contraceptive efficacy demographics follow-up prospective recruit reproductive research clinical testing reversible contraceptive screening side effect standard of care treatment arm

项目摘要

项目成果

MITCHELL CREININ的其他基金

相似基金

相关文献

中文摘要

翻译

LARC方法包括宫内节育器，植入物或长效阴道环，LARC方法比每日，每周或每月的产品更有效，因为它们不太容易出现用户错误。宫内节育器和植入物的有效率是典型使用的顶级。为了评估新的LARC产品是否可以有效避孕，并且可能导致停药的副作用发生率较低，将在NICHD避孕临床试验网络（CCTN）中进行前瞻性随机对照临床试验。

英文摘要

LARC methods include IUDs, implants, or long acting vaginal rings, LARC methods are more effective than daily, weekly or monthly products because they are less prone to user error. IUDs and implants have an effectiveness rate that is the top tier for typical use. In order to evaluate if new LARC products could be effective for contraception, and have a lower incidence of side effects that might lead to discontinuation, a prospective randomized controlled clinical trial will be conducted in the NICHD Contraceptive Clinical Trial Network (CCTN).

期刊论文(0)

专著(0)

科研奖励(0)

会议论文